Ticker > Company >

Vineet Laboratories share price

Vineet Laboratories Ltd.

  28.68 K   20   3 NSE: VINEETLAB BSE: 543298 SECTOR: Pharmaceuticals & Drugs

40.20
+1.80 (4.69%)
BSE: 20 Nov 04:01 PM

Price Summary

Today's High

₹ 41.3

Today's Low

₹ 38

52 Week High

₹ 43.56

52 Week Low

₹ 28

FinStar is Suspended!

The FinStar rating for this company is currently unavailable due to limited data disclosure. As a micro-cap company, it may carry higher risk and limited transparency. We will update the FinStar rating once more reliable data becomes available.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 77.21 Cr.

Enterprise Value

₹ 105.46 Cr.

No. of Shares

1.92 Cr.

P/E

24.07

P/B

1.63

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  24.59

CASH

₹ 17.07 Cr.

DEBT

₹ 45.33 Cr.

Promoter Holding

5.98 %

EPS (TTM)

₹  1.67

Sales Growth

-20.79%

ROE

3.69 %

ROCE

8.47%

Profit Growth

105.5 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-20.79%
3 Year-34.59%
5 Year-24.58%

Profit Growth

1 Year105.5%
3 Year-3.92%
5 Year-11.15%

ROE%

1 Year3.69%
3 Year-25.03%
5 Year-9.83%

ROCE %

1 Year8.47%
3 Year-3.17%
5 Year4.47%

Debt/Equity

0.9939

Price to Cash Flow

-6.31

Interest Cover Ratio

1.2626

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2026 5.98 0.00
Jun 2026 5.98 0.00
Mar 2026 5.98 0.00
Dec 2025 12.46 0.00
Sep 2025 15.89 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company’s PEG ratio is 0.234553082540773.

 Limitations

  • The company has shown a poor profit growth of -3.92301215293268% for the Past 3 years.
  • The company has shown a poor revenue growth of -34.5934864613382% for the Past 3 years.
  • Company has a poor ROE of -25.0337666666667% over the past 3 years.
  • Company has a poor ROCE of -3.16603333333333% over the past 3 years
  • Company has negative cash flow from operations of -12.2448.
  • The company has a low EBITDA margin of 1.5672% over the past 5 years.
  • The company is trading at a high PE of 24.07.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Net Sales 17.42 15.65 18.89 10.39 14.18
Total Expenditure 14.25 13.16 16.4 8.14 11.86
Operating Profit 3.18 2.49 2.5 2.25 2.32
Other Income 0.01 0.05 0.03 0.11 0.02
Interest 2.19 1.1 0.99 0.97 0.34
Depreciation 0.63 0.63 0.54 0.6 0.6
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.37 0.82 1 0.79 1.39
Tax -0.03 -0.03 0.27 -0.73 1.28
Profit After Tax 0.4 0.85 0.73 1.51 0.12
Adjusted EPS (Rs) 0.36 0.92 0.38 0.79 0.06

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales 191.17 212.29 150.59 75 59.4
Total Expenditure 178.01 204.63 143.39 91.28 50.92
Operating Profit 13.16 7.66 7.2 -16.28 8.48
Other Income 0.29 0.12 0.46 1.99 0.1
Interest 2.09 3.38 4.78 3.98 4.89
Depreciation 2.02 2.37 2.52 2.5 2.41
Exceptional Items 0 0 0 0 0
Profit Before Tax 9.35 2.03 0.36 -20.78 1.28
Tax 2.71 0.78 -0.66 -0.58 0.17
Net Profit 6.6 1.25 1.03 -20.19 1.11
Adjusted EPS (Rs.) 6.05 1.14 0.94 -18.4 0.58

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity and Liabilities
Share Capital 9.22 9.22 9.22 9.22 19.21
Total Reserves 24 24.46 25.51 5.43 26.4
Borrowings 1.72 4.85 3.89 3.79 10.21
Other N/C liabilities 3.61 2.81 2.27 1.72 1.69
Current liabilities 94.77 74.51 76 74.39 67.28
Total Liabilities 133.32 115.85 116.87 94.54 124.78
Assets
Net Block 21.38 26.65 26.92 25.46 24.24
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0.14 0.13 0.18 0.21 0.19
Loans & Advances 9.09 1.61 1.59 1.48 1.52
Other N/C Assets 0 0 0 0 0
Current Assets 102.7 87.46 88.19 67.39 98.83
Total Assets 133.32 115.85 116.87 94.54 124.78
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Profit from operations 9.35 2.03 0.36 -20.78 1.28
Adjustment 3.9 5.97 6.78 8.44 7.21
Changes in Assets & Liabilities -2.43 -14.63 -13.5 23.95 -20.74
Tax Paid -3.18 -2.99 -0.25 -0.12 0
Operating Cash Flow 7.63 -9.62 -6.61 11.49 -12.24
Investing Cash Flow -3.68 -6.69 -2.22 -3.18 -1.11
Financing Cash Flow 11.96 0.27 8.43 -8.23 29.74
Net Cash Flow 15.91 -16.03 -0.4 0.08 16.39

Corporate Actions

Investors Details

PARTICULARS Sep 2025% Dec 2025% Mar 2026% Jun 2026% Sep 2026%
promoters 15.89 12.46 5.98 5.98 5.98
a prabhakar raju 1.25 1.04 0.50 0.50 0.50
a ranga raju 1.31 0.81 0.39 0.39 0.39
a srinivasa raju 1.18 1.02 0.49 0.49 0.49
alluri anantha laxmi 0.82 0.71 0.34 0.34 0.34
alluri mythili 1.14 0.59 0.29 0.29 0.29
gaddam balaji 0.01 0.01 0.01 0.01 0.01
gaddam srinivasarao 0.39 0.39 0.19 0.19 0.19
gaddam venkata rama 0.27 0.27 0.13 0.13 0.13
gaddam venkata ramana 6.32 5.12 2.46 2.46 2.46
p kishore raju 0.57 0.53 0.25 0.25 0.25
penmetsa venkata krishnam... 0.69 0.52 0.25 0.25 0.25
satyanarayana raju bhupat... - - - - 0.69
v varaprasada raoin300513... - - - - 0.01
satyanarayana raju bhupat... 1.92 1.43 0.69 0.69 -
v varaprasada rao 0.01 0.01 0.01 0.01 -
kandula murali mohan 0.01 0.01 - - -
PARTICULARS Sep 2025% Dec 2025% Mar 2026% Jun 2026% Sep 2026%
investors 84.11 87.54 94.02 94.02 94.02
ajay agrawal 1.53 1.53 1.53 1.53 1.53
arjun aggarwal 1.52 1.52 - - 9.79
charan reddy puli - - - - 1.08
galaxy prime private limi... - - - - 2.60
jyoti agarwal 1.39 1.39 1.39 1.39 1.39
madhu nalajala - - 1.33 2.40 2.41
mangal keshav capital lim... - - - - 4.17
rajeev makkar - - - - 1.05
rajendra agrawal 1.57 1.57 1.57 1.57 1.57
rajesh poddar 4.48 4.48 2.15 2.15 2.15
sujata kumari jha - - - - 1.42
suraj wealth management p... - - - - 1.12
surekha naga lakshmi pend... 4.37 3.14 1.51 1.51 1.51
anasuya gorla 1.47 1.47 1.58 1.58 -
arjun aggarwal - - 11.35 11.35 -
iswarya gajjala - - 1.62 1.62 -
palloli rama chandra redd... - - 1.86 1.86 -
sudha madhu sudhan reddy - - 1.61 1.61 -
manchuri manohar reddy - - 1.57 - -
venkata sesha reddy mudim... - - 1.22 - -
seetaramanjaneyulu n 1.07 1.07 - - -
virochan mehta 1.03 1.03 - - -

Annual Reports

Title Link
Title Link
 No Annual reports exist for this company.Report us

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit and Research reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation and Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

Vineet Laboratories informs about newspaper advertisement 12 Nov, 2:00 PM Vineet Laboratories informs about disclosure 28 Nov, 10:07 AM Vineet Laboratories informs about offer letter draft for right issue 27 Nov, 5:32 PM Vineet Laboratories - Quaterly Results 9 Nov, 12:00 AM Vineet Laboratories informs about updates 4 Oct, 4:18 PM Vineet Laboratories - Quaterly Results 22 Jul, 4:51 PM Vineet Laboratories - Quaterly Results 22 Jul, 4:51 PM Vineet Laboratories - Quaterly Results 22 Jul, 4:51 PM Vineet Laboratories - Quaterly Results 12 May, 8:02 PM Vineet Laboratories - Quaterly Results 12 May, 8:02 PM Vineet Laboratories informs about certificate 16 Apr, 3:32 PM Vineet Laboratories informs about board meeting 13 Feb, 11:24 AM Vineet Laboratories - Quaterly Results 12 Feb, 5:36 PM Vineet Laboratories - Quaterly Results 12 Feb, 5:36 PM Vineet Laboratories informs about board meeting 4 Feb, 2:43 PM Vineet Laboratories informs about newspaper publication 5 Sep, 5:25 PM Vineet Laboratories submits intimation of book closure 4 Sep, 3:51 PM Vineet Laboratories - Quaterly Results 13 Aug, 6:21 PM Vineet Laboratories - Quaterly Results 13 Aug, 6:21 PM Vineet Laboratories - Quaterly Results 12 Feb, 5:06 PM Vineet Laboratories - Quaterly Results 12 Feb, 5:06 PM Vineet Laboratories informs about board meeting 2 Nov, 5:15 PM Vineet Laboratories informs about compliance certificate 13 Oct, 2:24 PM Vineet Laboratories informs about newspaper advertisement 14 Jun, 5:01 PM Vineet Laboratories informs about compliances-certificate 6 Apr, 4:37 PM Vineet Laboratories informs about disclosure 20 Mar, 1:40 PM Vineet Laboratories informs about board meeting 7 Feb, 3:11 PM Vineet Laboratories informs about trading window closure 30 Dec, 5:08 PM Vineet Laboratories - Quaterly Results 29 Jul, 4:15 PM Vineet Laboratories - Quaterly Results 29 Jul, 4:15 PM Vineet Laboratories - Quaterly Results 29 Jul, 4:15 PM Vineet laboratories informs about closure of trading window 31 Mar, 3:29 PM Vineet laboratories informs about postponement of AGM 31 Aug, 3:36 PM Vineet laboratories informs about closure of trading window 15 Jun, 4:27 PM

Vineet Laboratories Stock Price Analysis and Quick Research Report. Is Vineet Laboratories an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Vineet Laboratories. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Vineet Laboratories has a PE ratio of 23.9908971134268 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Vineet Laboratories has ROA of 1.0129% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Vineet Laboratories has a Current ratio of 1.4688.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Vineet Laboratories has a ROE of 3.6873%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Vineet Laboratories has a Debt to Equity ratio of 0.9939 which means that the company has low proportion of debt in its capital.

  • Sales growth: Vineet Laboratories has reported revenue growth of -20.7934% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Vineet Laboratories for the current financial year is 14.2740021211764%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Vineet Laboratories is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Vineet Laboratories is Rs 1.6698. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Vineet Laboratories in Ticker for free. Also, one can get the intrinsic value of Vineet Laboratories by using Valuation Calculators, which are available with a Finology ONE subscription. 

Vineet Laboratories FAQs

Q1. What is Vineet Laboratories share price today?
Ans: The current share price of Vineet Laboratories is Rs 40.06.

Q2. What is the market capitalisation of Vineet Laboratories?
Ans: Vineet Laboratories has a market capitalisation of Rs 76.940301596 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Vineet Laboratories?
Ans: The PE ratio of Vineet Laboratories is 23.9908971134268 and the P/B ratio of Vineet Laboratories is 1.62897841176638, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Vineet Laboratories share?
Ans: The 52-week high share price of Vineet Laboratories is Rs 43.5, and the 52-week low share price of Vineet Laboratories is Rs 27.96.

Q5. Does Vineet Laboratories pay dividends?
Ans: Currently, Vineet Laboratories does not pay dividends. Dividend yield of Vineet Laboratories is around 0%.

Q6. What are the face value and book value of Vineet Laboratories shares?
Ans: The face value of Vineet Laboratories shares is Rs 10, while the book value per share of Vineet Laboratories is around Rs 24.5921. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Vineet Laboratories?
Ans: Vineet Laboratories has a total debt of Rs 45.3254 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Vineet Laboratories?
Ans: The ROE of Vineet Laboratories is 3.6873% and ROCE of Vineet Laboratories is 8.4711%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Vineet Laboratories a good buy for the long term?
Ans: The Vineet Laboratories long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Vineet Laboratories undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Vineet Laboratories appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Vineet Laboratories’s financials?
Ans: You can review Vineet Laboratories’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Vineet Laboratories
X